BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 15800329)

  • 21. Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme.
    Groves MD; Puduvalli VK; Hess KR; Jaeckle KA; Peterson P; Yung WK; Levin VA
    J Clin Oncol; 2002 Mar; 20(5):1383-8. PubMed ID: 11870183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971.
    van den Bent MJ; Taphoorn MJ; Brandes AA; Menten J; Stupp R; Frenay M; Chinot O; Kros JM; van der Rijt CC; Vecht ChJ; Allgeier A; Gorlia T;
    J Clin Oncol; 2003 Jul; 21(13):2525-8. PubMed ID: 12829671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality assurance of the EORTC 26981/22981; NCIC CE3 intergroup trial on radiotherapy with or without temozolomide for newly-diagnosed glioblastoma multiforme: the individual case review.
    Ataman F; Poortmans P; Stupp R; Fisher B; Mirimanoff RO
    Eur J Cancer; 2004 Jul; 40(11):1724-30. PubMed ID: 15251162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined thalidomide and temozolomide treatment in patients with glioblastoma multiforme.
    Baumann F; Bjeljac M; Kollias SS; Baumert BG; Brandner S; Rousson V; Yonekawa Y; Bernays RL
    J Neurooncol; 2004; 67(1-2):191-200. PubMed ID: 15072467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase II study of extended low-dose temozolomide in recurrent malignant gliomas.
    Khan RB; Raizer JJ; Malkin MG; Bazylewicz KA; Abrey LE
    Neuro Oncol; 2002 Jan; 4(1):39-43. PubMed ID: 11772431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temozolomide in second-line treatment after prior nitrosurea-based chemotherapy in glioblastoma multiforme: experience from a Portuguese institution.
    Teixeira MM; Garcia I; Portela I; Cernuda M; Oliveira C; Albano J; Lima L
    Int J Clin Pharmacol Res; 2002; 22(1):19-22. PubMed ID: 12395915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can we afford to add chemotherapy to radiotherapy for glioblastoma multiforme? Cost-identification analysis of concomitant and adjuvant treatment with temozolomide until patient death.
    Wasserfallen JB; Ostermann S; Pica A; Mirimanoff RO; Leyvraz S; Villemure JG; Stupp R
    Cancer; 2004 Nov; 101(9):2098-105. PubMed ID: 15389472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II, two-arm RTOG trial (94-11) of bischloroethyl-nitrosourea plus accelerated hyperfractionated radiotherapy (64.0 or 70.4 Gy) based on tumor volume (> 20 or < or = 20 cm(2), respectively) in the treatment of newly-diagnosed radiosurgery-ineligible glioblastoma multiforme patients.
    Coughlin C; Scott C; Langer C; Coia L; Curran W; Rubin P
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1351-8. PubMed ID: 11121633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A population-based study on the effect of temozolomide in the treatment of glioblastoma multiforme.
    Rønning PA; Helseth E; Meling TR; Johannesen TB
    Neuro Oncol; 2012 Sep; 14(9):1178-84. PubMed ID: 22869622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A phase II study of temozolomide in patients with newly diagnosed supratentorial malignant glioma before radiation therapy.
    Gilbert MR; Friedman HS; Kuttesch JF; Prados MD; Olson JJ; Reaman GH; Zaknoen SL
    Neuro Oncol; 2002 Oct; 4(4):261-7. PubMed ID: 12356356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase I study of temozolamide (TMZ) combined with procarbazine (PCB) in patients with gliomas.
    Newlands ES; Foster T; Zaknoen S
    Br J Cancer; 2003 Jul; 89(2):248-51. PubMed ID: 12865911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II trial of cisplatin plus temozolomide, in recurrent and progressive malignant glioma patients.
    Silvani A; Eoli M; Salmaggi A; Lamperti E; Maccagnano E; Broggi G; Boiardi A
    J Neurooncol; 2004 Jan; 66(1-2):203-8. PubMed ID: 15015788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: results of a multiinstitutional study (SJHG-98).
    Broniscer A; Iacono L; Chintagumpala M; Fouladi M; Wallace D; Bowers DC; Stewart C; Krasin MJ; Gajjar A
    Cancer; 2005 Jan; 103(1):133-9. PubMed ID: 15565574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temozolomide in patients with glioblastoma at second relapse after first line nitrosourea-procarbazine failure: a phase II study.
    Brandes AA; Ermani M; Basso U; Paris MK; Lumachi F; Berti F; Amistà P; Gardiman M; Iuzzolino P; Turazzi S; Monfardini S
    Oncology; 2002; 63(1):38-41. PubMed ID: 12187069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous low-dose chemotherapy plus inhibition of cyclooxygenase-2 as an antiangiogenic therapy of glioblastoma multiforme.
    Tuettenberg J; Grobholz R; Korn T; Wenz F; Erber R; Vajkoczy P
    J Cancer Res Clin Oncol; 2005 Jan; 131(1):31-40. PubMed ID: 15565458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. One week on/one week off: a novel active regimen of temozolomide for recurrent glioblastoma.
    Wick W; Steinbach JP; Küker WM; Dichgans J; Bamberg M; Weller M
    Neurology; 2004 Jun; 62(11):2113-5. PubMed ID: 15184628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas.
    Glantz M; Chamberlain M; Liu Q; Litofsky NS; Recht LD
    Cancer; 2003 May; 97(9):2262-6. PubMed ID: 12712481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Survival analysis following the addition of temozolomide to surgery and radiotherapy in patients with glioblastoma multiforme].
    Gil-Salú JL; Román P; Benítez E; Maestro E; Pérez-Requena J; López-Escobar M
    Neurocirugia (Astur); 2004 Apr; 15(2):144-50. PubMed ID: 15159792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase 2 study of temozolomide and Caelyx in patients with recurrent glioblastoma multiforme.
    Chua SL; Rosenthal MA; Wong SS; Ashley DM; Woods AM; Dowling A; Cher LM
    Neuro Oncol; 2004 Jan; 6(1):38-43. PubMed ID: 14769139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined radiotherapy and temozolomide in patients with recurrent high grade glioma.
    Schönekaes K; Mücke R; Panke J; Rama B; Wagner W
    Tumori; 2002; 88(1):28-31. PubMed ID: 12004846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.